Iowa City, Iowa – The genetic defect responsible for cystic fibrosis (CF) may also directly contribute to the development of pancreatic cancer, according to a new study conducted in cell models. Researchers found that pancreatic cancer cells carrying CF-causing mutations grew faster and were more mobile than cancer cells without...

MELBOURNE, Australia and INDIANAPOLIS, Ind. — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patients in the United States (U.S.) have been dosed with Pixclara® (floretyrosine F 18 or 18F-FET), its FDA-approved, amino acid positron emission tomography (PET) drug for glioma (brain cancer) imaging. The...

CAMBRIDGE, Mass. — Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging its oligonucleotide promoted editing of RNA (OPERA®) platform to develop a new class of genetic medicines for rare and highly prevalent diseases, announced today that the first cohort of participants has been dosed in its Phase...